Scholars Central

Conference abstractPublished 6 May 2022

Neurovascular dysfunction in covid-19

Authors: Ramachandran Muthiah

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Viral infection is initiated from the surface spike glycoprotein, which binds to ACE2 receptor in brain vascular endothelium and smooth muscle cells and enter the cells by endocytosis. After priming by TMPRSS2 (transmembrane protease serine 2), it is activated and then internalized, results in an imbalance in homeostatic procoagulant and anticoagulant pathways, Cytokine storm, endothelial dysfunction and dysregulated activation of macrophages contributes to hyperinflammation and thrombosis. Overactivation of NADPH oxidase-2 (Nox2), resulting in increased reactive oxidant species, is implicated in arterial vasoconstriction, clotting, and platelet activation. Virus directly infecting stromal cells via interaction with CD13 or CD66a adhesion molecules andinduce platelet aggregation via PAC-1 binding. Persisting changes of blood cell physical phenotypes contribute to long-term microcirculatory dysfunction. Cytokines induce cytoskeletal changes in myeloid cells and erythrocytes and impaired oxygen delivery. In severe COVID-19, lowdensity phenotype that is prone to neutrophil extracellular trap formation (NET), with elevated size and deformability as a source of vascular occlusion. Sars-CoV-2 propagates in hematopoietic progenitor, erythroid, and megakaryocytic cells as the main cause of thrombotic events. Viral cytopathic effects in peripheral smear and the peculiar morphological findings would suspect a diagnosis in the absence of a negative RT-PCR or antibody results. The coagulopathy characterized by an increase in procoagulant factors such as fibrinogen with a strong increase of D-dimers have been associated with higher mortality. The incidence of cerebral infarction in COVID-19 is 4.5%. Thromboprophylaxis with LMWHs is recommended in hospitalized patients with high levels of D-dimer indicating hypercoagulative state. Intravenous recombinant tissue plasminogen activator (rt-PA) for selected patients. MSCs therapy could help to cure the inflammation and coagulopathy by a vascular effect. Very small embryonic like stem cells (VSELs) have endothelial angiogenic potential. Exogenous ACE2 with human recombinant soluble ACE2 is a novel treatment for stroke and reverse endothelial dysfunction. JAK inhibitors reduce hyperinflammation.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Neurology and Clinical Neuroscience.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Neurology and Clinical Neuroscience
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Ramachandran Muthiah”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels